|
1
|
Compston A: Progressive lenticular
degeneration: A familial nervous disease associated with cirrhosis
of the liver, by S. A. Kinnier Wilson, (from the national hospital,
and the laboratory of the national hospital, queen square, London)
brain 1912: 34; 295-509. Brain. 132:1997–2001. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Strickland GT, Chang NK and Beckner WM:
Hypersplenism in Wilson's disease. Gut. 13:220–224. 1972.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Poujois A and Woimant F: Wilson's disease:
A 2017 update. Clin Res Hepatol Gastroenterol. 42:512–520.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zeng DB, Di L, Zhang RC, Guo QL, Duan BW,
Jia CY, Chen F, Lin DD, Zang YJ and Lu SC: The effect of
splenectomy on the reversal of cirrhosis: A prospective study.
Gastroenterol Res Pract. 2019(5459427)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rabiner AM, et al: Hepatolenticular
degeneration following splenectomy, interrelationship of the
reticuloendothlial system and central nervous system. Arch Int Med,
1941.
|
|
6
|
Sternlieb I, Scheinberg IH and Walshe JM:
Bleeding oesophageal varices in patients with Wilson's disease.
Lancet. 1:638–641. 1970.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cai YL, Yang XT and Yang RM: Discussion on
splenectomy in hepatolenticular degeneration (with 42 cases
report). J Clin Neurol. 6:131–133. 1993.(In Chinese).
|
|
8
|
Li LY, Yang WM, Chen HZ, Wu YH, Fang X,
Zhang J, Wang Z, Han YS and Wang Y: Successful splenectomy for
hypersplenism in Wilson's disease: A single center experience from
China. PLoS One. 10(e0124569)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guo BB, Yu QS, Sheng Y, et al: Platelet
changes and its clinical significance in patients with
hepatolenticular degeneration complicated with hypersplenism before
and after splenectomy. J Liaoning Univ Tradit Chin Med. 21:134–137.
2019.(In Chinese).
|
|
10
|
Yang W, Yu QS and Pan JF: Effect of
platelet level on operation and prognosis in patients with
hepatolenticular degeneration and hypersplenism undergoing
splenectomy. Shaanxi Med J. 49:1403–1407. 2020.(In Chinese).
|
|
11
|
Wei FS, Yu QS, Pan JF, Shen Y, Zhang Q,
Wang Z and Hunag L: Effect of splenectomy on liver function in
patients with hepatolenticular degeneration and hypersplenism.
Guangxi Med. 42:2475–2491. 2020.(In Chinese).
|
|
12
|
Wang XM, Zhang FZ, Yu QS, et al:
Plenectomy in the treatment of hepatolenticular degeneration with
hypersplenism in children. J Hepatobiliary Pancreat Surg.
19:217–219. 2007.(In Chinese).
|
|
13
|
Qian Y, Pan JF, Huang L, Wang Z, Jing W
and Yu Q: Hepatolenticular degeneration with moderate to severe
hypersplenism Analysis of related factors of complications after
splenectomy. Shandong Med J. 62:63–66. 2022.(In Chinese).
|
|
14
|
Carry PM, Vanderlinden LA, Dong F, Buckner
T, Litkowski E, Vigers T, Norris JM and Kechris K: Inverse
probability weighting is an effective method to address selection
bias during the analysis of high dimensional data. Genet Epidemiol.
45:593–603. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang RM: Hepatolenticular degeneration.
9th Edition. People's Health Publishing House, Beijing, 2015.
|
|
16
|
Rosencrantz R and Schilsky M: Wilson
disease: Pathogenesis and clinical considerations in diagnosis and
treatment. Semin Liver Dis. 31:245–259. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ferenci P, Caca K, Loudianos G,
Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D and Berr
F: Diagnosis and phenotypic classification of Wilson disease. Liver
Int. 23:139–142. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hou Y and Sun GX: Diagnostic
classification criteria and clinical significance of hypersplenism
in portal hypertension. J Mod Integr Tradit Chin West Med.
18(3603)2009.(In Chinese).
|
|
19
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649.
1973.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou XX, Qin HL, He RX, Chen DB, Wu C,
Feng L, Li XH and Liang XL: Clinical characteristics of patients
with delayed hepatolenticular degeneration. Zhonghua Nei Ke Za Zhi.
58:501–507. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
21
|
Mansournia MA and Altman DG: Inverse
probability weighting. BMJ. 352(i189)2016.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Rubin DB: Estimating causal effects from
large data sets using propensity scores. Ann Intern Med.
127:757–763. 1997.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu L, Nevo D, Nishihara R, Cao Y, Song M,
Twombly TS, Chan AT, Giovannucci EL, VanderWeele TJ, Wang M and
Ogino S: Utility of inverse probability weighting in molecular
pathological epidemiology. Eur J Epidemiol. 33:381–392.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yoshizumi T, Itoh S, Shimokawa M, Inokuchi
S, Harada N, Takeishi K, Mano Y, Yoshiya S, Kurihara T, Nagao Y, et
al: Simultaneous splenectomy improves outcomes after adult living
donor liver transplantation. J Hepatol. 74:372–379. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Brauer DL, Rapoport AP, Yanovich S and
Akpek G: Splenectomy as a measure to treat prolonged
post-transplant cytopenia associated with hypersplenism. Bone
Marrow Transplant. 49:717–719. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Inagaki Y, Sugimoto K, Shiraki K, Tameda
M, Kusagawa S, Nojiri K, Ogura S, Yamamoto N, Takei Y, Ito M, et
al: The long-term effects of splenectomy and subsequent interferon
therapy in patients with HCV-related liver cirrhosis. Mol Med Rep.
9:487–492. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
McKenzie CV, Colonne CK, Yeo JH and Fraser
ST: Splenomegaly: Pathophysiological bases and therapeutic options.
Int J Biochem Cell Biol. 94:40–43. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Schwabl P, Seeland BA, Riedl F, Schubert
TL, Königshofer P, Brusilovskaya K, Petrenko O, Hofer B, Schiefer
AI, Trauner M, et al: Splenectomy ameliorates portal pressure and
anemia in animal models of cirrhotic and non-cirrhotic portal
hypertension. Adv Med Sci. 67:154–162. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yamamoto N, Okano K, Oshima M, Akamoto S,
Fujiwara M, Tani J, Miyoshi H, Yoneyama H, Masaki T and Suzuki Y:
Laparoscopic splenectomy for patients with liver cirrhosis:
Improvement of liver function in patients with Child-Pugh class B.
Surgery. 158:1538–1544. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Shi XB, Feng JK, Wang JH and Jiang XQ:
Does splenectomy significantly improve the prognosis of
hepatocellular carcinoma patients with hypersplenism? A systematic
review and meta-analysis. Ann Transl Med. 9(641)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang MJ, Ling WW, Wang H, Meng LW, Cai H
and Peng B: Non-invasive evaluation of liver stiffness after
splenectomy in rabbits with CCl4-induced liver fibrosis.
World J Gastroenterol. 22:10166–10179. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang Y, Guo X, Jiao G, Luo L, Zhou L,
Zhang J and Wang B: Splenectomy promotes macrophage polarization in
a mouse model of concanavalin A-(ConA-) Induced liver fibrosis.
Biomed Res Int. 2019(5756189)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Elchaninov AV, Fatkhudinov TK, Vishnyakova
PA, Nikitina MP, Lokhonina AV, Makarov AV, Arutyunyan IV,
Kananykhina EY, Poltavets AS, Butov KR, et al: Molecular mechanisms
of splenectomy-induced hepatocyte proliferation. PLoS One.
15(e0233767)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liang QS, Xie JG, Yu C, Feng Z, Ma J,
Zhang Y, Wang D, Lu J, Zhuang R and Yin J: Splenectomy improves
liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT)
through the JNK/TGF-β1 signaling pathway. Exp Mol Med. 53:393–406.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zheng Z, Wang H, Li L, Zhang S, Zhang C,
Zhang H, Ji F, Liu X, Zhu K, Kong G and Li Z: Splenectomy enhances
the Ly6Clow phenotype in hepatic macrophages by
activating the ERK1/2 pathway during liver fibrosis. Int
Immunopharmacol. 86(106762)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zeng DB, Di L, Guo QL, Ding J, Zhao XF and
Lu SC: Splenectomy with portoazygous disconnection for correction
of systemic hemodynamic disorders in hepatic cirrhosis patients
with portal hypertension: A prospective single-center cohort study.
Can J Gastroenterol Hepatol. 2020(8893119)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Weledji EP: Benefits and risks of
splenectomy. Int J Surg. 12:113–119. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Członkowska A, Litwin T, Dusek P, Ferenci
P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH and Schilsky ML:
Wilson disease. Nat Rev Dis Primers. 4(21)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Grasedyck K: D-penicillamine-side effects,
pathogenesis and decreasing the risks. Z Rheumatol. 47 (Suppl
1):S17–S19. 1988.PubMed/NCBI(In German).
|
|
40
|
Langan MN and Thomas P:
Penicillamine-induced liver disease. Am J Gastroenterol.
82:1318–1319. 1987.PubMed/NCBI
|
